Vance R. Brown
Known title: SVP, GC and Corp. SecretaryCIK: 0001868243
Associated companies
Transaction History
| BSX | ▲ Buy | Option Exercise | 1,839 | $0 | 2/16/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 890 | $67K | 2/16/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,851 | $0 | 2/14/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 895 | $67K | 2/14/2026 | View on chart |
| BSX | ▲ Buy | Grant | 14,804 | $0 | 2/13/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,118 | $0 | 2/13/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 12,792 | $956K | 2/13/2026 | View on chart |
| BSX | ▲ Buy | Grant | 14,804 | $0 | 2/13/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 488 | $36K | 2/12/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,442 | $0 | 2/12/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,036 | $0 | 7/1/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,952 | $205K | 7/1/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 4,826 | $514K | 5/21/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 4,826 | $459K | 4/21/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 4,826 | $487K | 3/21/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 4,826 | $505K | 2/21/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,000 | $0 | 2/17/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 484 | $51K | 2/17/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,839 | $0 | 2/16/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 890 | $94K | 2/16/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,850 | $0 | 2/14/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 895 | $95K | 2/14/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,442 | $0 | 2/12/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 424 | $45K | 2/12/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 6,350 | $673K | 2/11/2025 | View on chart |
| BSX | ▲ Buy | Grant | 14,708 | $0 | 2/11/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 6,456 | $0 | 1/1/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,991 | $178K | 1/1/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,036 | $0 | 7/1/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,952 | $149K | 7/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 15,006 | $407K | 5/22/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 15,006 | $1.1M | 5/22/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 18,037 | $443K | 5/21/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 18,037 | $1.4M | 5/21/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 218 | $14K | 2/18/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 741 | $0 | 2/18/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,000 | $0 | 2/17/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 294 | $19K | 2/17/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,838 | $0 | 2/16/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 540 | $36K | 2/16/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,850 | $0 | 2/14/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 629 | $41K | 2/14/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 15,750 | $796K | 8/25/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,036 | $0 | 7/1/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,359 | $74K | 7/1/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 229 | $11K | 2/21/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 779 | $0 | 2/21/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 741 | $0 | 2/18/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 218 | $10K | 2/18/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,000 | $0 | 2/17/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 294 | $14K | 2/17/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,838 | $0 | 2/16/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 568 | $26K | 2/16/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 923 | $0 | 2/15/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 323 | $15K | 2/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,394 | $0 | 10/2/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 997 | $39K | 10/2/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 4,035 | $0 | 7/1/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,185 | $45K | 7/1/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,019 | $0 | 2/28/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 300 | $13K | 2/28/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 779 | $0 | 2/21/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 230 | $10K | 2/21/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 741 | $0 | 2/18/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 214 | $9K | 2/18/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,000 | $0 | 2/17/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 332 | $14K | 2/17/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 923 | $0 | 2/15/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 323 | $14K | 2/15/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,393 | $0 | 10/2/2021 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,137 | $50K | 10/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate
Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.